Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer.

ACS Med Chem Lett · 2019 · PMC6580371 · PMID 31223438

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

A trend toward increase CD8+ cytolytic T cells and TNFα expression was also observed (see Supporting Information ); however, those markers failed to reach statistical significance in this study.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.